James Pickens Jr. reveals prostate cancer diagnosis, credits early detection that saved his life

James Pickens Jr., the actor who plays Dr. Richard Webber on the long-running medical drama “Grey’s Anatomy,” has announced his own prostate cancer diagnosis. The 71-year-old star revealed he underwent a successful robotic prostatectomy earlier this year. He is now using his platform to urge men, particularly Black men, to prioritize routine health screenings.

His real-life health battle emerged publicly just as his television character faced a similar storyline. Pickens confirmed his diagnosis in November, calling himself “living proof” that early detection saves lives. According to reports from CNN, his prognosis is excellent because the cancer was caught at a very early, localized stage.

Real-Life Drama Mirrors On-Screen Storyline

The timing of the announcement was striking. It coincided with the “Grey’s Anatomy” midseason finale where his character, the stalwart Chief of Surgery, received a cancer diagnosis.

Pickens shared that his own journey began in 2024. His primary care physician noticed concerning numbers in a routine blood test. This led to a referral to a urologist for further investigation.

Subsequent tests, including an MRI and a biopsy, confirmed the presence of a tumor. A PET scan then provided crucial news. It showed the cancer had not spread beyond the prostate gland.

He underwent a robotic prostatectomy in January 2025. The procedure was successful. Pickens has since made a strong recovery and continues to be a central figure on the show.

The Critical Importance of Proactive Screening

Pickens’s experience highlights a vital public health message. The American Cancer Society states that 1 in 8 men will be diagnosed with prostate cancer in their lifetime. For Black men, the risk is significantly higher.

They are about twice as likely to develop and die from prostate cancer compared to other racial groups. This disparity makes early and regular screening absolutely essential.

Pickens had been diligent about his health for decades. He began annual physicals over thirty years ago. Knowing prostate cancer ran in his family, he started PSA (Prostate-Specific Antigen) blood tests well before standard recommendation ages.

This vigilance is what doctors say made all the difference. When prostate cancer is detected early, the five-year survival rate is over 99%. Pickens’s case is a textbook example of a positive outcome through proactive healthcare.

James Pickens Jr.’s courageous disclosure brings a powerful, human face to the life-saving importance of prostate cancer screening. His story is a compelling reminder that early detection truly is the best protection.

Thought you’d like to know

What is a PSA test?

A PSA test is a blood test that measures the level of prostate-specific antigen. It is a common screening tool for prostate cancer. Elevated levels can indicate a problem, but they do not always mean cancer is present.

At what age should men start getting screened?

Men should discuss screening with their doctor starting at age 50. Black men and those with a family history should start this conversation earlier, around age 40 or 45. A doctor can provide personalized advice based on individual risk factors.

What are the symptoms of prostate cancer?

Early-stage prostate cancer often has no symptoms. Symptoms that may appear later include difficulty urinating, blood in the urine or semen, and bone pain. This is why screening is so crucial before symptoms develop.

How effective is the robotic prostatectomy procedure?

Robotic prostatectomy is a minimally invasive surgery with a high success rate for localized prostate cancer. It typically offers benefits like less blood loss, a shorter hospital stay, and a faster recovery compared to traditional open surgery.

Why is prostate cancer risk higher for Black men?

The reasons are complex and not fully understood. Factors may include genetics, health care access disparities, and environmental influences. This increased risk makes targeted awareness and early screening campaigns vitally important.

Trusted Sources

American Cancer Society, CNN, National Cancer Institute